Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue
AMCP sends letters to all 100 Senators supporting S. 974, the CREATES Act
On behalf of the Academy of Managed Care Pharmacy (AMCP), I am writing to express our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation designed to increase patient access to safe and affordable generic and biosimilar medicines and marketplace competition. AMCP was pleased that the bill continued to garner bipartisan support when it was voted out of the Judiciary Committee. We are seeking your support for the bill now that the bill is on the Senate Legislative Calendar.
Related
AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
